Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 26 07 2019
accepted: 10 12 2019
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 5 11 2020
Statut: epublish

Résumé

Select residues in the biantennary sugar moiety attached to the fragment crystallizable of immunoglobulin G (IgG) antibodies can modulate IgG effector functions. Thus, afucosylated IgG glycovariants have enhanced cytotoxic activity, whereas IgG glycovariants rich in terminal sialic acid residues can trigger anti-inflammatory effects. More recent evidence suggests that terminal α2,6 linked sialic acids can be attached to antibodies post IgG secretion. These findings raise concerns for the use of therapeutic antibodies as they may change their glycosylation status in the patient and hence affect their activity. To investigate to what extent B cell extrinsic sialylation processes modify therapeutic IgG preparations

Identifiants

pubmed: 31998308
doi: 10.3389/fimmu.2019.03024
pmc: PMC6970187
doi:

Substances chimiques

Immunoglobulin Fc Fragments 0
Immunoglobulin G 0
Immunoglobulins, Intravenous 0
Polysaccharides 0
Sialic Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3024

Informations de copyright

Copyright © 2020 Schaffert, Hanić, Novokmet, Zaytseva, Krištić, Lux, Nitschke, Peipp, Pezer, Hennig, Rapp, Lauc and Nimmerjahn.

Références

J Immunol. 1989 Oct 15;143(8):2595-601
pubmed: 2507634
Crit Rev Biotechnol. 2018 Sep;38(6):851-867
pubmed: 29262720
Mol Immunol. 1990 Nov;27(11):1145-53
pubmed: 2174119
Nat Rev Immunol. 2008 Jan;8(1):34-47
pubmed: 18064051
Eur J Immunol. 2014 May;44(5):1444-53
pubmed: 24505033
Nature. 1991 Apr 4;350(6317):423-6
pubmed: 1901381
Science. 2006 Aug 4;313(5787):670-3
pubmed: 16888140
Nat Chem Biol. 2018 May;14(5):516-524
pubmed: 29632412
J Lab Clin Med. 1988 Nov;112(5):634-40
pubmed: 3183495
Biochem J. 1989 Apr 15;259(2):347-53
pubmed: 2524188
Nat Rev Rheumatol. 2017 Oct;13(10):621-630
pubmed: 28905852
Proteomics. 2016 May;16(9):1321-30
pubmed: 26960168
Glycobiology. 1996 Apr;6(3):271-9
pubmed: 8724135
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4265-70
pubmed: 18332429
Cell Rep. 2014 Apr 10;7(1):236-48
pubmed: 24685130
Front Immunol. 2012 Jan 11;2:96
pubmed: 22566885
PLoS One. 2011;6(6):e21246
pubmed: 21731683
J Leukoc Biol. 2017 Aug;102(2):507-516
pubmed: 28550122
Nat Rev Immunol. 2013 Mar;13(3):176-89
pubmed: 23411799
Proteomics. 2001 Feb;1(2):340-9
pubmed: 11680880
Eur J Immunol. 2007 Oct;37(10):2973-82
pubmed: 17899548
Annu Rev Immunol. 1998;16:421-32
pubmed: 9597136
Glycobiology. 1995 Dec;5(8):741-58
pubmed: 8720072
MAbs. 2019 Feb/Mar;11(2):350-372
pubmed: 30466347
J Exp Med. 2007 Jan 22;204(1):11-5
pubmed: 17227911
Mol Cell Proteomics. 2011 Oct;10(10):M111.010090
pubmed: 21653738
Mol Immunol. 2000 Feb-Mar;37(3-4):107-13
pubmed: 10865109
J Proteome Res. 2008 Apr;7(4):1650-9
pubmed: 18311910
Glycobiology. 2017 Jan;27(2):188-198
pubmed: 27798070
J Immunol. 2019 Mar 1;202(5):1582-1594
pubmed: 30683704
Immunol Rev. 2010 Jul;236:265-75
pubmed: 20636822
Methods Mol Biol. 2015;1331:123-43
pubmed: 26169738
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):7207-12
pubmed: 27303031
Mol Cell Proteomics. 2014 Jun;13(6):1598-610
pubmed: 24719452
Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G833-42
pubmed: 21292995
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1901-1906
pubmed: 29432186
Science. 2005 Dec 2;310(5753):1510-2
pubmed: 16322460
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4504-9
pubmed: 9539767
J Biol Chem. 1994 Jul 8;269(27):17872-8
pubmed: 8027041
J Biol Chem. 2003 Jan 31;278(5):3466-73
pubmed: 12427744
Science. 2008 Apr 18;320(5874):373-6
pubmed: 18420934
Eur J Immunol. 2012 Apr;42(4):826-30
pubmed: 22278120
Glycobiology. 2000 May;10(5):477-86
pubmed: 10764836
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15005-9
pubmed: 18815375
J Immunol Methods. 2012 Aug 31;382(1-2):167-76
pubmed: 22683540
Cell Rep. 2015 Dec 22;13(11):2376-2385
pubmed: 26670049
J Biol Chem. 2017 Aug 18;292(33):13514-13520
pubmed: 28717006
Biotechnol Bioeng. 2019 Apr;116(4):816-830
pubmed: 30552760

Auteurs

Anja Schaffert (A)

Department of Biology, Institute of Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.

Maja Hanić (M)

Glycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.

Mislav Novokmet (M)

Glycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.

Olga Zaytseva (O)

Glycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.

Jasminka Krištić (J)

Glycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.

Anja Lux (A)

Department of Biology, Institute of Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.

Lars Nitschke (L)

Department of Biology, Institute of Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.

Matthias Peipp (M)

Department of Medicine II, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.

Marija Pezer (M)

Glycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.

René Hennig (R)

glyXera GmbH, Magdeburg, Germany.
Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.

Erdmann Rapp (E)

glyXera GmbH, Magdeburg, Germany.
Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.

Gordan Lauc (G)

Glycoscience Research Laboratory, Genos Ltd., Zagreb, Croatia.
Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.

Falk Nimmerjahn (F)

Department of Biology, Institute of Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH